Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDE | P14735 | 1/20 | 0.77 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.56 |
| ▸ | MEN1 | O00255 | 6/20 | 0.56 |
| ▸ | MAPT | P10636 | 3/20 | 0.56 |
| ▸ | MYC | P01106 | 1/20 | 0.52 |
| ▸ | NPC1 | O15118 | 1/20 | 0.52 |
| ▸ | GAA | P10253 | 4/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.44 |
| ▸ | THRB | P10828 | 2/20 | 0.44 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.44 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.44 |
| ▸ | MMP2 | P08253 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | HNF4A | P41235 | 1/20 | 0.44 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5704809 | 0.90 | IDE (0.60) | IDEKMT2AMEN1MAPTMYC | |
| SCHEMBL29401042 | 0.87 | IDE (1.00) | IDEKMT2AMEN1MAPTMYC | |
| SCHEMBL453285 | 0.87 | IDE (1.00) | IDEKMT2AMEN1MAPTMYC | |
| SCHEMBL453284 | 0.87 | IDE (1.00) | IDEKMT2AMEN1MAPTMYC | |
| SCHEMBL12100493 | 0.87 | IDE (1.00) | IDEKMT2AMEN1MAPTMYC | |
| SCHEMBL623529 | 0.85 | MEN1 (0.70) | IDEKMT2AMEN1MAPTMYC | |
| SCHEMBL1252583 | 0.84 | IDE (0.66) | IDEKMT2AMEN1MAPTMYC | |
| SCHEMBL3860617 | 0.78 | CYP3A4 (0.47) | IDEKMT2AMAPTMYCGAA | |
| SCHEMBL10992403 | 0.77 | IDE (0.70) | IDEKMT2AMEN1MAPTMYC | |
| SCHEMBL21501069 | 0.77 | IDE (0.70) | IDEKMT2AMEN1MAPTMYC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 224 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3137905-A1 | METHOD OF ISOLATING A TARGET CELL | IBA GmbH (DE) | 2017-03-08 | — | — | EP | claimed |
| US-20170052176-A1 | METHOD OF ISOLATING A TARGET CELL | IBA LIFESCIENCES GMBH (DE) | 2017-02-23 | — | — | US | claimed |
| WO-2015166049-A1 | METHOD OF ISOLATING A TARGET CELL | IBA GMBH (DE) | 2015-11-05 | — | — | WO | claimed |
| EP-1769247-A1 | BIOTIN RECOGNITION SENSORS AND HIGH-THROUGHPUT ASSAYS | Molecular Probes, Inc. (US) | 2007-04-04 | — | — | EP | claimed |
| US-20050208598-A1 | Biotin recognition sensors and high-throughput assays | MOLECULAR PROBES, INC. | 2005-09-22 | — | — | US | claimed |
| WO-2005080989-A1 | BIOTIN RECOGNITION SENSORS AND HIGH-THROUGHPUT ASSAYS | MOLECULAR PROBES, INC. (US) | 2005-09-01 | — | — | WO | claimed |
| EP-0414848-B1 | BIOCOMPATIBLE MATERIALS COMPRISING ALBUMIN-BINDING DYES | EATON JOHN W (US) | 1995-10-11 | — | — | EP | claimed |
| EP-0414848-A4 | BIOCOMPATIBLE MATERIALS COMPRISING ALBUMIN-BINDING DYES | — | 1992-12-16 | — | — | EP | claimed |
| US-5073171-A | Solid polymeric body incorporating an albumin-binding dye to form a protective coating; anticoagulants; antiinflammatory agents | EATON JOHN W (US) | 1991-12-17 | — | — | US | claimed |
| EP-0414848-A1 | BIOCOMPATIBLE MATERIALS COMPRISING ALBUMIN-BINDING DYES. | EATON JOHN W (US) | 1991-03-06 | — | — | EP | claimed |
| WO-1990007950-A1 | BIOCOMPATIBLE MATERIALS COMPRISING ALBUMIN-BINDING DYES | EATON JOHN W (US) | 1990-07-26 | — | — | WO | claimed |
| EP-4180811-B1 | METHODS OF ISOLATING A BIOLOGICAL ENTITY | CELL COPEDIA GMBH (DE) | 2025-04-09 | — | — | EP | disclosed |
| US-12195556-B2 | Reversible protein multimers, methods for their production and use | LUDWIG INSTITUTE FOR CANCER RESEARCH LTD. (US) | 2025-01-14 | — | — | US | disclosed |
| US-12181440-B2 | Nitrogen-driven desorption by a diazirine | NORTHEASTERN UNIVERSITY (US) | 2024-12-31 | — | — | US | disclosed |
| US-20240329039-A1 | METHODS OF ISOLATING A BIOLOGICAL ENTITY | Cell.Copedia GmbH (DE) | 2024-10-03 | — | — | US | disclosed |
| WO-1990007950-A1 | BIOCOMPATIBLE MATERIALS COMPRISING ALBUMIN-BINDING DYES | EATON JOHN W (US) | 1990-07-26 | — | — | WO | disclosed |
| EP-0218962-B1 | IMPROVED BIOTINYLATED PEROXIDASE | MILES INC. (US) | 1990-01-24 | — | — | EP | disclosed |
| US-4724203-A | IMMUNOHISTOCHEMICAL MEASUREMENT | MILES LABORATORIES, INC. (US) | 1988-02-09 | — | — | US | disclosed |
| US-4656252-A | Amidobiotin compounds useful in a avidin-biotin multiple layering process | GIESE ROGER W | 1987-04-07 | — | — | US | disclosed |
| US-4116633-A | Globulin test | PITMAN-MOORE, INC. (US) | 1978-09-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12195556-B2 | Reversible protein multimers, methods for their production and use | CD4, CD74, MICA | IDE 2772/4885KMT2A 3065/4885MEN1 3716/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.